These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30948167)

  • 101. Active and prospective latent tuberculosis are associated with different metabolomic profiles: clinical potential for the identification of rapid and non-invasive biomarkers.
    Albors-Vaquer A; Rizvi A; Matzapetakis M; Lamosa P; Coelho AV; Patel AB; Mande SC; Gaddam S; Pineda-Lucena A; Banerjee S; Puchades-Carrasco L
    Emerg Microbes Infect; 2020 Dec; 9(1):1131-1139. PubMed ID: 32486916
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Untargeted metabolomic profiling reveals molecular signatures associated with type 2 diabetes in Nigerians.
    Doumatey AP; Shriner D; Zhou J; Lei L; Chen G; Oluwasola-Taiwo O; Nkem S; Ogundeji A; Adebamowo SN; Bentley AR; Gouveia MH; Meeks KAC; Adebamowo CA; Adeyemo AA; Rotimi CN
    Genome Med; 2024 Mar; 16(1):38. PubMed ID: 38444015
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Clinical metabolomics by NMR revealed serum metabolic signatures for differentiating sarcoidosis from tuberculosis.
    Rai MK; Yadav S; Jain A; Singh K; Kumar A; Raj R; Dubey D; Singh H; Guleria A; Chaturvedi S; Khan AR; Nath A; Misra DP; Agarwal V; Kumar D
    Metabolomics; 2023 Nov; 19(11):92. PubMed ID: 37940751
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Tuberculosis is associated with sputum metabolome variations, irrespective of patient sex or HIV status: an untargeted GCxGC-TOFMS study.
    Beukes D; van Reenen M; Loots DT; du Preez I
    Metabolomics; 2023 Jun; 19(6):55. PubMed ID: 37284915
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Benchtop NMR-Based Metabolomics: First Steps for Biomedical Application.
    Alonso-Moreno P; Rodriguez I; Izquierdo-Garcia JL
    Metabolites; 2023 Apr; 13(5):. PubMed ID: 37233655
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Biomarker discovery for tuberculosis using metabolomics.
    Yu Y; Jiang XX; Li JC
    Front Mol Biosci; 2023; 10():1099654. PubMed ID: 36891238
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Exploration of Lipid Metabolism Alterations in Children with Active Tuberculosis Using UHPLC-MS/MS.
    Sun B; Liu F; Yin Q; Jiang T; Fang M; Duan L; Quan S; Tian X; Shen A; Mi K; Sun L
    J Immunol Res; 2023; 2023():8111355. PubMed ID: 36815950
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Tuberculous Granuloma: Emerging Insights From Proteomics and Metabolomics.
    Sholeye AR; Williams AA; Loots DT; Tutu van Furth AM; van der Kuip M; Mason S
    Front Neurol; 2022; 13():804838. PubMed ID: 35386409
    [No Abstract]   [Full Text] [Related]  

  • 109. Molecular perturbations in pulmonary tuberculosis patients identified by pathway-level analysis of plasma metabolic features.
    Phuoc Long N; Heo DY; Park S; Thi Hai Yen N; Cho YS; Shin JG; Oh JY; Kim DH
    PLoS One; 2022; 17(1):e0262545. PubMed ID: 35073339
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Metabolomics as a Tool to Investigate HIV/TB Co-Infection.
    Liebenberg C; Luies L; Williams AA
    Front Mol Biosci; 2021; 8():692823. PubMed ID: 34746228
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Deciphering the mechanism of action of antitubercular compounds with metabolomics.
    Sakallioglu IT; Barletta RG; Dussault PH; Powers R
    Comput Struct Biotechnol J; 2021; 19():4284-4299. PubMed ID: 34429848
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Lymphocyte-Related Immunological Indicators for Stratifying
    Luo Y; Xue Y; Tang G; Cai Y; Yuan X; Lin Q; Song H; Liu W; Mao L; Zhou Y; Chen Z; Zhu Y; Liu W; Wu S; Wang F; Sun Z
    Front Immunol; 2021; 12():658843. PubMed ID: 34276653
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Metabolomics in infectious diseases and drug discovery.
    Tounta V; Liu Y; Cheyne A; Larrouy-Maumus G
    Mol Omics; 2021 Jun; 17(3):376-393. PubMed ID: 34125125
    [TBL] [Abstract][Full Text] [Related]  

  • 114. The pursuit of mechanism of action: uncovering drug complexity in TB drug discovery.
    Yuan T; Werman JM; Sampson NS
    RSC Chem Biol; 2021 Apr; 2(2):423-440. PubMed ID: 33928253
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Which Current and Novel Diagnostic Avenues for Bacterial Respiratory Diseases?
    Rytter H; Jamet A; Coureuil M; Charbit A; Ramond E
    Front Microbiol; 2020; 11():616971. PubMed ID: 33362754
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Insights gained into respiratory infection pathogenesis using lung tissue metabolomics.
    Bernatchez JA; McCall LI
    PLoS Pathog; 2020 Jul; 16(7):e1008662. PubMed ID: 32663224
    [No Abstract]   [Full Text] [Related]  

  • 117. The Echo of Pulmonary Tuberculosis: Mechanisms of Clinical Symptoms and Other Disease-Induced Systemic Complications.
    Luies L; du Preez I
    Clin Microbiol Rev; 2020 Sep; 33(4):. PubMed ID: 32611585
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Comprehensive Examination of the Mouse Lung Metabolome Following
    Fernández-García M; Rey-Stolle F; Boccard J; Reddy VP; García A; Cumming BM; Steyn AJC; Rudaz S; Barbas C
    J Proteome Res; 2020 May; 19(5):2053-2070. PubMed ID: 32285670
    [TBL] [Abstract][Full Text] [Related]  

  • 119. The Many Hosts of Mycobacteria 8 (MHM8): A conference report.
    Larsen MH; Lacourciere K; Parker TM; Kraigsley A; Achkar JM; Adams LB; Dupnik KM; Hall-Stoodley L; Hartman T; Kanipe C; Kurtz SL; Miller MA; Salvador LCM; Spencer JS; Robinson RT
    Tuberculosis (Edinb); 2020 Mar; 121():101914. PubMed ID: 32279870
    [TBL] [Abstract][Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.